Should a doctor prescribe hormone replacement therapy which has been manufactured from mare’s urine?

This research investigates the ethical implications of prescribing hormone replacement therapy (HRT) derived from mare’s urine. The paper concludes that it’s preferable for doctors to recommend synthetic estrogen to women, given it provides similar benefits to the menopause symptoms and health protection as HRT produced from mare’s urine, presumably causing less harm to mares.

Ethical Considerations

• The paper raises ethical questions on the utilization of hormone replacement therapies made from the urine of mares. It proposes that, while patients have the right to refuse treatments founded on their moral quandaries or beliefs, doctors also need to consider their ethical responsibility when recommending certain medications over others.

Assessment of Alternatives

• With the premise that mares potentially suffer during the manufacture of equine HRT, the author argues that its prescription must be justified by either greater health benefits to the woman or better cost-efficiency for the health service, compared to synthetic variants like oestriol.

Evidence Exploration

• Reviewing the existing evidence, the research finds no substantial proof that equine HRT provides distinct advantages over synthetic oestrogen-oestriol. This means that there’s no clear-cut health or cost justification for prescribing equine-derived HRT over synthetic alternatives.

Conclusion

• Given the potential ethical concerns on mare welfare and the lack of proven superior health or cost benefits, the paper ultimately concludes that doctors should primarily recommend synthetic oestrogen to women seeking relief from menopausal symptoms and protection against osteoporosis or cardiovascular disease.